Medicine & Life Sciences
Proton Pump Inhibitors
100%
Pharmacokinetics
89%
Pharmaceutical Preparations
63%
Acids
61%
Cimetidine
59%
1-N-methyl-5-thiotetrazole
58%
Permeability
51%
Stomach
49%
Propranolol
46%
glycylsarcosine
46%
Generic Drugs
41%
Critical Care
40%
Anti-Bacterial Agents
40%
Cefotetan
38%
Dipeptides
38%
cellulose triacetate
36%
Cefoxitin
35%
Ranitidine
35%
Cefoperazone
35%
Bacterial Pneumonia
34%
peptide permease
33%
Pharmacists
32%
Cefmetazole
31%
Critical Illness
28%
Hypoprothrombinemias
28%
Pantoprazole
28%
Drug Interactions
28%
Caco-2 Cells
27%
Formularies
26%
Therapeutics
25%
Healthy Volunteers
25%
Paroxetine
25%
Omeprazole
24%
ATP Binding Cassette Transporter, Subfamily B, Member 1
23%
Moxalactam
23%
Hot Temperature
23%
Gastric Emptying
23%
Intensive Care Units
22%
Theophylline
22%
Pharmacology
21%
Digestion
21%
Verapamil
21%
Peptidomimetics
21%
Vancomycin
21%
polyethylene glycol 400
20%
Phenylalanine
20%
Sucralfate
20%
Drug Therapy
19%
Economics
19%
Chemical Compounds
Proton Pump Inhibitor
61%
Drug
45%
Permeability
31%
Cimetidine
31%
Pharmacologic Agent
28%
Omeprazole
28%
Propranolol
22%
Pellet
22%
Cefmenoxime
19%
Phenylalanine
18%
Pharmaceutical
18%
Caffeine
18%
Lansoprazole
16%
Rabeprazole
16%
Antiulcer Agent
16%
Pantoprazole
16%
Ranitidine
14%
Piroxicam
13%
Cyclosporin A
13%
Marker
13%
Antagonist
11%
Plasma
10%
Pharmaceutical Industry
10%
Reversed Phase HPLC
9%
Ion Pair
8%
Cefoxitin
8%
Safety
8%
Acid
8%
Enteric Coating
7%
Dose
7%
Surfactant
6%
Peff
6%
Pharmacokinetics
5%
Liquid
5%
Tetrabutylammonium
5%
Ammonium Acetate
5%